Protective Effects of Baicalein on Lipopolysaccharide-Induced AR42J PACs through Attenuation of Both Inflammation and Pyroptosis via Downregulation of miR-224-5p/PARP1
Background. Baicalein has been used to treat inflammation-related diseases; nevertheless, its specific mechanism of action is unclear. Therefore, we examined the protective effects of baicalein on lipopolysaccharide-induced damage to AR42J pancreatic acinar cells (PACs) and determined its mechanism...
Saved in:
Main Authors: | Ming-Wei Liu (Author), Chun-Hai Zhang (Author), Shou-Hong Ma (Author), De-Qiong Zhang (Author), Li-Qiong Jiang (Author), Yang Tan (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Baicalein inhibits inflammatory response and promotes osteogenic activity in periodontal ligament cells challenged with lipopolysaccharides
by: Manman Ren, et al.
Published: (2021) -
Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway
by: Ma X, et al.
Published: (2016) -
Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling Pathway
by: Jian-ning Zhang, et al.
Published: (2019) -
Baicalein Attenuates Pyroptosis and Endoplasmic Reticulum Stress Following Spinal Cord Ischemia-Reperfusion Injury via Autophagy Enhancement
by: Chenyu Wu, et al.
Published: (2020) -
AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
by: Zhu Y, et al.
Published: (2019)